"This increased our interest in the epidermal growth factor receptor (EGFR) pathway because previous work indicated that it ...

and produce low levels of human epidermal growth factor receptor 2 (HER2). Although drugs exist that can block mutant PI3K, ...

HER3 (also known as ERBB3) is a crucial member of the Epidermal Growth Factor Receptor (EGFR) family. It plays a significant role in cellular proliferation, survival, and differentiation via the ...

However, screening can be a challenging and time-consuming process. The team tested their new method to screen drugs that can ...

Human epidermal growth factor receptor 2 (HER2) proteins are found on the surface of breast cells and are involved in normal ...

A new study describes the development of a biologic, a drug derived from natural biological systems, that targets a mutant cancer protein called HER2 (human epidermal growth factor receptor 2 ...

When complex multicellular organisms grow and develop, their tissues must undergo remodeling. As new cells begin to proliferate, old ...

Morgan Stanley analyst Judah Frommer has maintained their bullish stance on BCAX stock, giving a Buy rating yesterday. Judah Frommer’s ...

Drugs that target advanced breast cancer could help patients with a rare cancer that affects parts of the digestive system, a ...

“Onco360 is grateful for the opportunity to partner with the team at Genentech and become a specialty pharmacy provider for Itovebi ™ ,” said Benito Fernandez. “We are proud to add another treatment ...

Doctors once thought non-small-cell lung cancer (NSCLC) was one disease. Most people got the same treatment -- chemotherapy (chemo) -- especially if their cancer had spread to other parts of the body.

Veru, Inc. is a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of metabolic diseases, oncology, and ARDS. The company’s drug development ...